Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...
Hosted on MSN2d
We’ll Know If Half-Life 3 Is Great From The First Level
After years of waiting, fans are finally confident that Half-Life 3 is real and coming soon. I count myself among their numbers — enough signs point to the long-awaited, once-cancelled sequel being in ...